Detalles de la búsqueda
1.
Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study.
Blood
; 141(14): 1675-1684, 2023 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36542826
2.
Combining nilotinib and PD-L1 blockade reverses CD4+ T-cell dysfunction and prevents relapse in acute B-cell leukemia.
Blood
; 140(4): 335-348, 2022 07 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35275990
3.
Plain language summary of the TRANSFORM study primary analysis results: lisocabtagene maraleucel as a second treatment regimen for large B-cell lymphoma following failure of the first treatment regimen.
Future Oncol
; 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38547003
4.
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial.
Lancet
; 399(10343): 2294-2308, 2022 06 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35717989
5.
Temporal variation in oral microbiome composition of patients undergoing autologous hematopoietic cell transplantation with keratinocyte growth factor.
BMC Microbiol
; 23(1): 258, 2023 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37704974
6.
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma.
Am J Hematol
; 98(3): 464-471, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36629030
7.
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.
Am J Hematol
; 98(6): 900-912, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36965007
8.
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
N Engl J Med
; 380(1): 45-56, 2019 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30501490
9.
Impact of initial chemotherapy regimen on outcomes for patients with double-expressor lymphoma: A multi-center analysis.
Hematol Oncol
; 39(4): 473-482, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34347909
10.
Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival.
Eur J Haematol
; 107(3): 301-310, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33973276
11.
Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era.
Am J Hematol
; 96(11): 1374-1384, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34324220
12.
Surveillance Imaging after Autologous Hematopoietic Cell Transplantation Predicts Survival in Patients with Diffuse Large B Cell Lymphoma.
Biol Blood Marrow Transplant
; 26(2): 272-277, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31669174
13.
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic.
Biol Blood Marrow Transplant
; 26(7): 1239-1246, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32298807
14.
Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse.
Blood
; 132(25): 2639-2642, 2018 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30266774
15.
Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up.
Biol Blood Marrow Transplant
; 25(1): 56-62, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30077015
16.
Hematopoietic Cell Transplant-Related Toxicities and Mortality in Frail Recipients.
Biol Blood Marrow Transplant
; 25(12): 2454-2460, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31394273
17.
Donor Killer Cell Immunoglobulin-Like Receptor Genotype Does Not Improve Graft-versus-Leukemia Responses in Chronic Lymphocytic Leukemia after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis.
Biol Blood Marrow Transplant
; 25(5): 949-954, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30594542
18.
Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy.
Biol Blood Marrow Transplant
; 25(11): 2113-2123, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31446198
19.
Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
Biol Blood Marrow Transplant
; 25(12): 2305-2321, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31446199
20.
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(3): e76-e85, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30576834